Early-stage European VC firm Blossom Capital is fresh from closing a $185M fund— a big jump up on its prior close. The firm makes just a handful of investments per year, mostly at the Series A stage, working very closely with founders in its portfolio, a strategy it refers to as “high conviction” investing. One … Continue reading Blossom Capital’s Louise Samet talks hormone tracking and femtech bets